US2012197007A1PendingUtilityA1
METHOD FOR PURIFYING PEGylated ERYTHROPOIETIN
Est. expirySep 14, 2030(~4.2 yrs left)· nominal 20-yr term from priority
A61K 47/60C07K 1/18A61K 38/1816A61K 47/50A61K 38/18B01D 15/36Y02P20/582C07K 14/505B01J 39/26
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Herein is reported a method for the purification of a protein comprising erythropoietin and a single poly(ethylene glycol) residue from reaction by-products or not reacted starting material by a cation exchange chromatography method. It has been found that by employing a cation exchange SP Sephacryl™ S 500 HR chromatography material conditioned to a conductivity of 21 mS/cm and a linear gradient elution a fusion protein of erythropoietin and a single poly(ethylene glycol) residue can be obtained in a single step with high purity and yield.
Claims
exact text as granted — not AI-modified1 . A method for obtaining a protein, which comprises erythropoietin and a single poly(ethylene glycol) residue, comprising the following steps:
a) applying a solution comprising a mixture of erythropoietin and conjugates of erythropoietin and poly(ethylene glycol) with one or more poly(ethylene glycol) residues per erythropoietin molecule to a column, comprising SP Sephacryl™ S 500 HR chromatography material, to which a solution with a conductivity of about 21 mS/cm has been applied, b) applying a solution with a conductivity of about 21 mS/cm to the column and thereby recovering free poly(ethylene glycol), and proteins comprising two or more poly(ethylene glycol) residues, c) applying a solution with linearly increasing conductivity up to a final value of about 62.5 mS/cm to the column and thereby recovering separately the protein, which comprises erythropoietin and a single poly(ethylene glycol) residue, and erythropoietin, whereby the protein comprising erythropoietin and a single poly(ethylene glycol) residue is recovered first.
2 . The method according to claim 1 , characterized in that the solution with a conductivity of about 21 mS/cm is a solution with a pH value of from pH 2.5 to pH 3.5.
3 . The method according to any one of the preceding claims, characterized in that the solution with a conductivity of about 21 mS/cm is a phosphate buffered solution with a pH value of from pH 2.5 to pH 3.5.
4 . The method according to any one of the preceding claims, characterized in that the solution comprising a mixture of erythropoietin and conjugates of erythropoietin and poly(ethylene glycol) with one or more poly(ethylene glycol) residues per erythropoietin molecule is not adjusted to a conductivity of about 21 mS/cm.
5 . The method according to any one of the preceding claims, characterized in that the solution with linearly increasing conductivity is a solution with linearly increasing sodium chloride concentration.
6 . The method according to any one of the preceding claims, characterized in that the solution with linearly increasing conductivity has a pH value of from pH 2.3 to pH 3.5.
7 . The method according to any one of the preceding claims, characterized in that the erythropoietin is human erythropoietin.
8 . The method according to claim 7 , characterized in that the human erythropoietin has the amino acid sequence of SEQ ID NO: 01 or SEQ ID NO: 02.
9 . The method according to any one of the preceding claims, characterized in that the single poly(ethylene glycol) residue has a molecular weight of from 20 kDa to 40 kDa.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.